
Aridis Pharmaceuticals ARDS
Aridis Pharmaceuticals Langfristiger Schuldenstrom | ARDS
Langfristiger Schuldenstrom Jährlich Aridis Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 538 K | - | - | - | - | - | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 538 K | 538 K | 538 K |
Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Entera Bio Ltd.
ENTX
|
230 K | $ 3.24 | -0.31 % | $ 150 M | ||
|
Legend Biotech Corporation
LEGN
|
7.4 M | $ 20.25 | -16.63 % | $ 7.46 B | ||
|
CytomX Therapeutics
CTMX
|
4.24 M | $ 2.0 | 0.76 % | $ 276 M | ||
|
Krystal Biotech
KRYS
|
1.77 M | $ 306.47 | 1.13 % | $ 8.87 B | ||
|
Kura Oncology
KURA
|
1.28 M | $ 7.56 | -0.13 % | $ 663 M | ||
|
Inhibikase Therapeutics
IKT
|
150 K | $ 1.58 | -6.25 % | $ 155 M | ||
|
Heron Therapeutics
HRTX
|
3.04 M | $ 0.38 | 1.38 % | $ 63.3 M | ||
|
Inovio Pharmaceuticals
INO
|
2.82 M | $ 1.47 | -2.98 % | $ 68.9 M | ||
|
Corvus Pharmaceuticals
CRVS
|
403 K | $ 11.36 | 0.09 % | $ 897 M | ||
|
Aytu BioScience
AYTU
|
221 K | $ 1.83 | 2.23 % | $ 22.5 M | ||
|
Innoviva
INVA
|
418 K | $ 19.08 | 0.39 % | $ 1.29 B | ||
|
BioCardia
BCDA
|
442 K | $ 0.95 | 2.66 % | $ 6.33 M | ||
|
Alterity Therapeutics Limited
ATHE
|
66.9 K | $ 2.3 | -5.35 % | $ 14.7 B | ||
|
Certara
CERT
|
3.92 M | $ 12.21 | -0.08 % | $ 1.96 B | ||
|
Dyadic International
DYAI
|
34.6 K | $ 0.39 | 1.16 % | $ 14.1 M | ||
|
Anika Therapeutics
ANIK
|
2.05 M | $ 13.42 | -7.89 % | $ 192 M | ||
|
Aprea Therapeutics
APRE
|
256 K | $ 0.45 | -9.44 % | $ 2.94 M | ||
|
Galectin Therapeutics
GALT
|
22 K | $ 3.4 | -1.73 % | $ 217 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
1.08 M | $ 73.22 | -2.41 % | $ 7.6 B | ||
|
BioMarin Pharmaceutical
BMRN
|
8.57 M | $ 57.1 | -0.14 % | $ 11 B | ||
|
Matinas BioPharma Holdings
MTNB
|
694 K | $ 1.19 | -4.03 % | $ 6.51 M | ||
|
Enanta Pharmaceuticals
ENTA
|
3.15 M | $ 11.24 | -2.01 % | $ 240 K | ||
|
SIGA Technologies
SIGA
|
595 K | $ 3.14 | -3.83 % | $ 225 M | ||
|
Milestone Pharmaceuticals
MIST
|
647 K | $ 0.68 | -7.49 % | $ 72.2 M | ||
|
Kiniksa Pharmaceuticals, Ltd.
KNSA
|
2.99 M | $ 94.9 | -3.91 % | $ 7.04 B | ||
|
PTC Therapeutics
PTCT
|
12.5 M | $ 64.12 | -1.4 % | $ 5.1 B | ||
|
Seres Therapeutics
MCRB
|
10.4 M | $ 1.55 | -8.75 % | $ 13.7 M | ||
|
Madrigal Pharmaceuticals
MDGL
|
1.02 M | $ 432.48 | -0.07 % | $ 9.7 B | ||
|
CEL-SCI Corporation
CVM
|
167 K | $ 1.41 | 4.07 % | $ 11.3 M | ||
|
MeiraGTx Holdings plc
MGTX
|
2.85 M | $ 9.62 | 1.37 % | $ 774 M | ||
|
Processa Pharmaceuticals
PCSA
|
66.9 K | $ 1.86 | -4.62 % | $ 2.44 M | ||
|
Eton Pharmaceuticals
ETON
|
65 K | $ 67.5 | 4.9 % | $ 1.82 B | ||
|
IDEAYA Biosciences
IDYA
|
339 K | $ 31.72 | -0.97 % | $ 2.81 B | ||
|
Protalix BioTherapeutics
PLX
|
1.38 M | $ 2.86 | 11.28 % | $ 225 M | ||
|
Lantern Pharma
LTRN
|
78.5 K | $ 0.47 | -22.86 % | $ 5.12 M | ||
|
Foghorn Therapeutics
FHTX
|
923 K | $ 1.89 | -7.35 % | $ 119 M | ||
|
Ocugen
OCGN
|
858 K | $ 0.95 | -2.45 % | $ 297 M |